#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neonatal alloimmune thrombocytopenia Primary amyloidosis Myxoid liposarcoma Oesophageal carcinoma Metastatic malignant melanoma Warm autoimmune haemolytic anaemia Fragile X syndrome Leiomyosarcoma metastatic Still's disease Focal segmental glomerulosclerosis Heavy menstrual bleeding Central nervous system neoplasm B-cell small lymphocytic lymphoma refractory Malignant central nervous system neoplasm Waldenstrom's macroglobulinaemia recurrent More trials…

    Learn about Rare Diseases

    Immunodeficiency congenital – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Pleomorphic leiomyosarcoma – Diagnostics Leiomyosarcoma recurrent Mantle cell lymphoma – Treatment Basal cell naevus syndrome – Diagnostics Waldenstrom’s macroglobulinaemia recurrent Noonan syndrome – Basic Information Congenital nephrogenic diabetes insipidus – Treatment Prolymphocytic leukaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Argon Vemircopan Histidine Paroxetine Hydrochloride Pemigatinib Varnimcabtagene Autoleucel Imsidolimab GSKVX000000034798 Clemastine Fumarate Mebufotenin Noradrenaline Tartrate Hexaminolevulinate DAPIGLUTIDE L-ARGININE POLYMYXIN B SULFATE Carbamazepine (Ph. Eur.) Ecopipam Hydrochloride Folic Acid, Anhydrous Relebactam Nitric Oxide More therapies…

    Learn about Your Condition

    Metastases to meninges Extra-osseous Ewing's sarcoma Perinatal depression Pyoderma Vesicoureteric reflux Adrenal insufficiency Hyperkalaemia Candida infection Follicular lymphoma stage III HER2 positive gastric cancer Hypomagnesaemia Transitional cell carcinoma Primary amyloidosis Thyroid cancer Meningococcal infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on How Well Etavopivat Works for Adolescents and Adults with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    Belgium France Greece Italy The Netherlands Spain

  • Study on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida

    Recruiting

    3 1 1
    Investigated Diseases:
    • Spina bifida
    Investigated Drugs:
    • OXYBUTYNIN HYDROCHLORIDE
    France

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    3 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Dronabinol
    • Cannabidiol
    Spain

  • Study on the Effectiveness and Safety of Nizubaglustat in Patients with Niemann-Pick Type C, GM1, or GM2 Gangliosidosis

    Recruiting

    3 1
    Investigated Drugs:
    • NIZUBAGLUSTAT
    France Germany Italy Portugal Spain Sweden

  • Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

    Recruiting

    3 1 1
    Investigated Drugs:
    • Deucrictibant
    Austria Bulgaria France Germany Hungary Ireland +5

  • Study Comparing Metformin and Tolvaptan for Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Metformin
    • Tolvaptan
    Italy
Previous Page
1 … 6 7 8 9 10 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!